Gemcitabine and docetaxel as first-line treatment for advanced urothelial carcinoma: A phase II study

Gemcitabine and docetaxel as first-line treatment for advanced urothelial carcinoma: a phase II study

British Journal of Cancer ◽

10.1038/sj.bjc.6602378 ◽

2005 ◽

Vol 92 (4) ◽

pp. 645-650 ◽

Cited By ~ 50

Author(s):

A Ardavanis ◽

D Tryfonopoulos ◽

A Alexopoulos ◽

C Kandylis ◽

G Lainakis ◽

...

Keyword(s):

Urothelial Carcinoma ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Sequential gemcitabine and cisplatin followed by docetaxel as first-line treatment of advanced urothelial carcinoma: a multicenter phase II study of the Hellenic Oncology Research Group

Annals of Oncology ◽

10.1093/annonc/mdl286 ◽

2006 ◽

Vol 17 (11) ◽

pp. 1687-1692 ◽

Cited By ~ 10

Author(s):

I. Boukovinas ◽

N. Androulakis ◽

L. Vamvakas ◽

P. Papakotoulas ◽

N. Ziras ◽

...

Keyword(s):

Urothelial Carcinoma ◽

Research Group ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Oncology Research ◽

Multicenter Phase ◽

First Line Treatment ◽

Gemcitabine And Cisplatin

Vinflunine/gemcitabine versus carboplatin/gemcitabine as first-line treatment in cisplatin-ineligible patients with advanced urothelial carcinoma: A randomised phase II trial (VINGEM)

European Journal of Cancer ◽

10.1016/j.ejca.2019.08.033 ◽

2020 ◽

Vol 127 ◽

pp. 173-182 ◽

Cited By ~ 3

Author(s):

Karin Holmsten ◽

Niels Viggo Jensen ◽

Lene Sonne Mouritsen ◽

Erika Jonsson ◽

Camilla Mellnert ◽

...

Keyword(s):

Urothelial Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

First Line ◽

Gemcitabine combined with cisplatin as first-line treatment in patients 60 years or older with epithelial ovarian cancer: a phase II study

International Journal of Gynecological Cancer ◽

10.1046/j.1525-1438.2003.13039.x ◽

2003 ◽

Vol 13 (2) ◽

pp. 130-137 ◽

Cited By ~ 9

Author(s):

T. Bauknecht ◽

A. Hefti ◽

G. Morack ◽

C. Villena-Heinsen ◽

D. Wallwiener ◽

...

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Exemestane and Chemotherapy as First-line Treatment of Metastatic Breast Cancer: Results of a Phase II Study

Clinical Breast Cancer ◽

10.3816/cbc.2010.n.041 ◽

2010 ◽

Vol 10 (4) ◽

pp. 313-317 ◽

Cited By ~ 3

Author(s):

Juan de la Haba-Rodriguez ◽

Rosario González Mancha ◽

Gumersindo Pérez Manga ◽

Enrique Aranda Aguilar ◽

José Manuel Baena Cañada ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

Phase II study of carboplatin and 1-h intravenous etoposide and paclitaxel in a novel sequence as first-line treatment of patients with small-cell lung cancer

Lung Cancer ◽

10.1016/s0169-5002(02)00387-2 ◽

2003 ◽

Vol 39 (1) ◽

pp. 77-84 ◽

Cited By ~ 4

Author(s):

J.M Vieitez ◽

M Valladares ◽

M Gracia ◽

M Gonzalez-Barón ◽

G Martı́n ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II study

European Journal of Cancer ◽

10.1016/j.ejca.2014.12.020 ◽

2015 ◽

Vol 51 (4) ◽

pp. 473-481 ◽

Cited By ~ 10

Author(s):

Maria Di Bartolomeo ◽

Andrea Ciarlo ◽

Alessandro Bertolini ◽

Sandro Barni ◽

Claudio Verusio ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Advanced Colorectal Cancer ◽

Medical Oncology ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Docetaxel, Vinorelbine, and Zoledronic Acid as First-Line Treatment in Patients with Hormone Refractory Prostate Cancer: A Phase II Study

European Urology ◽

10.1016/j.eururo.2007.02.060 ◽

2007 ◽

Vol 52 (4) ◽

pp. 1020-1027 ◽

Cited By ~ 13

Author(s):

Giuseppe Di Lorenzo ◽

Riccardo Autorino ◽

Sisto Perdonà ◽

Michele De Laurentiis ◽

Massimo D'Armiento ◽

...

Keyword(s):

Prostate Cancer ◽

Zoledronic Acid ◽

Phase Ii ◽

Phase Ii Study ◽

Hormone Refractory Prostate Cancer ◽

Line Treatment ◽

First Line ◽

Hormone Refractory ◽

1652P A prospective, single-arm phase II study of pegylated-liposome doxorubincin combined with ifosfamide as first-line treatment for patients with advanced or metastatic soft tissue sarcoma

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1878 ◽

2020 ◽

Vol 31 ◽

pp. S986

Author(s):

X. Liu ◽

X. Zhang ◽

J. Cao ◽

H. Wang ◽

X. Wu ◽

...

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Pegylated Liposome ◽

Metastatic Soft Tissue Sarcoma ◽

Efficacy of Cisplatin-Based Chemotherapy as First-Line Treatment in Asian Patients with Metastatic Urothelial Carcinoma Results of an Exploratory Subgroup Analysis of a Pool Analysis of Phase II/III Trials

Annals of Oncology ◽

10.1016/s0923-7534(20)32244-4 ◽

2012 ◽

Vol 23 ◽

pp. xi96-xi97

Author(s):

C.-C. Lin ◽

M.D. Galsky ◽

S. Krege ◽

N.M. Hahn ◽

T. Ecke ◽

...

Keyword(s):

Urothelial Carcinoma ◽

Phase Ii ◽

Subgroup Analysis ◽

Pool Analysis ◽

Line Treatment ◽

First Line ◽

Asian Patients ◽

Metastatic Urothelial Carcinoma ◽